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RETROSPECTIVE STUDY 1 
 2 
Effect of Insulin and Fasting Regimen on Blood Glucose Concentrations of Diabetic 3 
Dogs during Phacoemulsification 4 
 5 
Abstract  6 
This study aimed to compare four protocols for preanesthetic insulin administration and 7 
fasting time with respect to the variation of intraoperative blood glucose (BG) concentrations 8 
versus preanesthetic values (baseline). The patient records of dogs undergoing cataract 9 
surgery were included. Data on anesthetic protocols, comorbidities, and intraoperative 10 
complications (hyper- and hypoglycemia, hypotension, hypothermia, and bradycardia) were 11 
analyzed. The insulin/fasting protocols included (A) 12 hr fasting and half insulin dose, (B) 6 12 
hr fasting and half insulin dose, (C) 12 hr fasting and full insulin dose, and (D) 12 hr fasting 13 
and no insulin. Forty-eight dogs were included (14 in A, 10 in B, 13 in C, and 11 in D). 14 
Protocol D resulted in a significant increase of intraoperative BG concentrations compared 15 
with baseline (P = .001), whereas in the remaining groups, the baseline BG did not differ 16 
from intraoperative values. There were no statistically significant associations between the 17 
treatment group and the occurrence of intraoperative complications or the presence of 18 
diagnosed comorbidities. In conclusion, different insulin and fasting regimen protocols may 19 
be used for diabetic patients with no apparent benefit or risk from one protocol versus 20 
another. The use of insulin before surgery results in lesser increase of BG intraoperatively as 21 
compared with preanesthetic values. However, whether this should be interpreted as better 22 
perioperative control of glycemia remains debatable. 23 
Abbreviations 24 
BG (Blood glucose); (BCS) Body Condition Score   25 
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Introduction 26 
Diabetes mellitus is a systemic disease whose prevalence in the canine population in 27 
the UK has been reported as 0.32%.1 Diabetic cataract is one of the most common 28 
complications of this endocrine disorder in dogs and can be treated surgically.2  29 
Diabetes mellitus poses some anesthetic challenges owing to the possible co-30 
morbidities such as kidney dysfunction, hyperadrenocorticism, systemic hypertension and 31 
peripheral neuropathies.3 In addition, chronic hyperglycemia with BG concentrations higher 32 
than the renal threshold (12-14 mmol/L) results in osmotic diuresis, dehydration and 33 
electrolyte imbalances such as hyponatremia, hypokalemia and hypophosphatemia. 3  34 
Changes in basal metabolism and body temperature, the stress response, the 35 
requirement for fasting and a disruption of the normal exercise routine, all of which 36 
ordinarily accompany anesthesia, have the potential to perturb the glycemic control of well 37 
medically controlled diabetic dogs. As a result, in diabetic patients, the risk of poor glucose 38 
regulation is likely to be increased in the perioperative period, which may exacerbate the 39 
deleterious effects of hyperglycemia on the body homeostasis. Besides hyperglycemia, 40 
diabetic dogs undergoing surgery may experience hypoglycemia as a result of a combination 41 
of administration of insulin and preanesthetic fasting. 42 
Although the perturbation of glucose homeostasis in diabetic patients is of concern 43 
among clinicians, the most effective insulin/fasting protocol in terms of optimal intra-44 
operative control of blood glucose (BG) concentrations has not been identified yet, and clear 45 
guidelines are lacking. Some authors have recommended SC administration of either a full or 46 
a fractional dose of insulin on the morning of the surgery after 12 hours of fasting.4,5 47 
However, the effectiveness of these protocols has never been evaluated. A more recent study 48 
compared a quarter of a dose of insulin versus a full dose administered before anesthesia in 49 
dogs fasted for 12 hours, and found that the full dose offered only marginal advantages over 50 
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the quarter-dose, as poorly controlled hyperglycemia developed in both cases.6 Some 51 
textbooks aimed at general practitioners provide guidelines on how to handle insulin and food 52 
for diabetic dogs the morning of surgery, but there is no general consensus between authors 53 
regarding the dose of insulin or the administration or withholding of food.3,7,8 As a result, the 54 
choice of the insulin/fasting protocol is based on the subjective preference of the clinician.  55 
The primary aim of this retrospective study was to compare 4 protocols for insulin dose 56 
and fasting time with respect to the variation of intra-operative BG concentrations versus pre-57 
anesthetic values (baseline), in diabetic dogs undergoing cataract surgery. A secondary aim 58 
was to determine whether there was an association between the choice of the insulin /fasting 59 
regimen and the occurrence of perianesthetic complications, namely hypothermia, 60 
hypotension, hyper- and hypoglycemia, and bradycardia. A further secondary objective was 61 
to investigate whether the choice of the anesthetic protocol could produce an effect on the 62 
intra-operative BG concentrations. 63 
The authors hypothesized that preoperative administration of insulin would maintain 64 
better glucose control and be associated with fewer intraoperative complications than 65 
withholding of insulin on the day of surgery in diabetic dogs. It was also hypothesized that 66 
poorly controlled intra-operative hyperglycemia would increase the risk for intra-operative 67 
complications.  68 
 69 
Materials and Methods 70 
Case selection criteria and medical records review  71 
The study was conducted under approval of the Clinical Research Ethical Review Board of 72 
the Royal Veterinary College (license number: 2017-1017).  73 
The medical records of all the dogs with diagnosed diabetes mellitus undergoing 74 
elective phacoemulsification at the Queen Mother Hospital for Animals (QMHA) of the 75 
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Royal Veterinary College between October 2012 and October 2017 were reviewed. The cases 76 
were identified through the database, by using the following key word-combinations: 77 
“dog/canine + diabetic/diabetes + anesthesia/anesthetic”, “dog/canine + insulin + 78 
anesthesia/anesthetic”, “dog/canine + cataract surgery”, and “dog/canine + 79 
phacoemulsification”. Additionally, a list of the canine patients undergoing 80 
phacoemulsification was obtained through the internal logbook for surgical procedures. The 81 
search was manually refined and the incomplete patient files, as well as the records of non-82 
diabetic dogs undergoing phacoemulsification, were excluded. Demographic data of the 83 
patients enrolled in the study (sex, age, breed and Body Condition Score (BCS)) were also 84 
collected and used for statistical analysis. Fructosamine serum concentrations, as well as the 85 
presence of co-morbidities, were noted when this information was available on the record. 86 
The last BG concentration measured in each patient before anesthesia was recorded as the 87 
pre-anesthetic BG value (baseline). The information on whether insulin and/or glucose were 88 
administered during the anaesthetic was also recorded. 89 
 90 
Definitions and treatment groups  91 
The following events occurring during anesthesia were considered peri-anesthetic 92 
complications and defined as follows: 93 
 Hyperglycemia (BG >250 mg/dL or 13.9 mmol/L);6 94 
 Hypoglycemia (BG <70 mg/dL or 3.9 mmol/L);6 95 
 Hypothermia (rectal body temperature <36.7 Celsius);9 96 
 Hypotension (either mean arterial pressure <54 mmHg measured with oscillometry, or 97 
as systolic arterial pressure  <90 mmHg measured with Doppler);10 and  98 
 Bradycardia (heart rate <60 beats per minute in the presence of hypotension as above 99 
defined).11 100 
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Clinician-dependent peri-operative insulin/fasting time regimen protocols used at our 101 
institution led to the identification of the following treatment groups:  102 
 Group A: half of the usual insulin dose administered SC on the morning of surgery in 103 
dogs fasted for 12 hours;  104 
 Group B: half of the usual insulin dose administered SC on the morning of surgery in 105 
dogs fasted for 6 hours; 106 
 Group C: the dog’s full insulin dose administered SC on the morning of surgery after 107 
12 hours fasting; and 108 
 Group D: fasting time set at 12 hours and no pre-operative insulin; intra-operative 109 
insulin to be administered at the anesthesist’s discretion based on the BG 110 
concentrations measured during the anesthetic. 111 
In order to investigate whether the choice of the anesthetic protocol could produce an effect 112 
on the intra-operative BG concentrations, all data were pulled together again using the 113 
anaesthetic protocol as a grouping factor. The following two possible treatment groups were 114 
identified, based on the most common anesthetists’ choices at the QMHA: 115 
 Group AO (Acepromazine-Opioid): acepromazinea and an opioid - either methadoneb 116 
or pethidinec or butorphanold in premedication; and 117 
 Group O (Opioid): opioid-based premedication (either methadone or pethidine or 118 
butorphanol). 119 
Whether animals received one or another premedication, they were induced with propofole 120 
or alfaxalonef followed by inhalational anesthesia with either sevofluraneg or isofluraneh 121 
delivered in oxygen.  122 
 123 
Data analysis  124 
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Descriptive statistics applied for demographic data. Normality of data was assessed with the 125 
Kolmogorov-Smirnov test. . Either one-way repeated measures analysis of variance or 126 
Friedman repeated measures analysis of variance on ranks were used, depending on data 127 
distribution, to evaluate changes in intraoperative BG concentrations within each treatment 128 
group, whereas the groups were compared with respect to the intraoperative BG 129 
concentrations with Kruskal-Wallis one-way analysis of variance on ranks. Item imputation 130 
was applied to substitute missing values.12 Two-way analysis of variance, with time and 131 
treatment (AO and O) as source of variation factors, was used to evaluate the effect of the 132 
anesthetic protocol on the BG concentrations over time. The proportions of dogs 133 
experiencing intra-operative complications, as well as of those receiving intraoperative 134 
insulin, within each set of treatment groups (A, B, C and D; AO and O) were analysed with 135 
χ2 and Fisher exact tests, respectively. For groups A–D comparisons, if an overall difference 136 
was detected between groups with respect to one of the aforementioned variables 137 
(intraoperative complications and intraoperative insulin administration), then the χ2 test was 138 
followed by an additional Fisher exact tests for pairwise comparison. 139 
Commercially available softwarei,j,k were used. P values lower than 0.05 were considered 140 
statistically significant.  141 
 142 
Results 143 
Data are presented as either means and standard deviation, or medians and interquartile (25 144 
and 75%) ranges, where it applies. 145 
The initial search identified 114 files that were then revised and screened. A total of 48 146 
dogs of various breeds, consisting of 31 (all of whom were castrated) and 17 females (15 of 147 
whom were spayed), all on treatment with an intermediate-acting insulin productl at the time 148 
of surgery, met the inclusion criteria and were included in the study. The 48 dogs still 149 
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included after screening were operated between January 2013 and December 2017. Dogs 150 
were prescribed a drop of dexamethasone phosphate 0.1%m to be applied topically onto the 151 
affected eye/s once every other day, or once daily, for as many days as the patient had to wait 152 
before the surgery, which was routinely between 2 to 14 days, depending on the surgery 153 
schedule. Immediately postoperatively, the same drops were continued for life. No other pre-154 
operative ocular medical treatment was regularly given with the exception of tropicamiden to 155 
dilate the pupil and topical flurbiprofeno, both given alternatively every 15 minutes for 1 156 
hour, 1 to 2 hours immediately before induction, in preparation for the pre-operative 157 
electroretinogram that was performed in all the patients. In the majority of the patients, the 158 
baseline BG concentrations were above the reference ranges provided for dogs by the 159 
laboratory of our institution (3.6–7.0 mg/dL), namely, 22 (19–30), 17 (12–22), 16 (15–26), 160 
and 17 (9–21) mg/dL in groups A, B, C, and D, respectively. The difference in baseline BG 161 
between groups was not statistically significant (P = .19). The proportion of 162 
nonhyperglycemic dogs (including both the hypoglycemic and the normoglycemic ones, 163 
based on the preanesthetic BG measurement) was lower in groups A (0%; n = 0) and B (9%; 164 
n = 1 normoglycemic dog) than in the remaining groups C (30%; n = 3 normoglycemic dogs) 165 
and D (36%; n = 1 hypoglycemic dog and 3 normoglycemic dogs).6 This difference was 166 
statistically significant (P = .013). IV atracuriump was administered intraoperatively to all 167 
patients (dose range: .1–.3 mg/kg). The neuromuscular block was monitored through a nerve 168 
stimulator with a train-of-four stimulating pattern, and reversed with intramuscular 169 
neostigmineq (dose range: .01–.03 mg/kg) and glycopyrroniumr (dose range: .01–.02 mg/kg) 170 
at the end of surgery, if the train-of-four ratio was <.9.13 Intermittent positive-pressure 171 
ventilation was provided to all dogs during the neuromuscular block. 172 
Data pertaining age (119±24 months) and fructosamines serum concentrations (502 ± 234 173 
µmol/L; n = 12) showed normal distribution, whereas total BG concentration (including 174 
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preanesthetic and intraoperative values in all groups; 19 [12–27] mg/dL) was not normally 175 
distributed. Six out of the 12 measured fructosamines serum concentrations were >500 176 
µmol/L. Body condition score (5 [4–5]/9) was recorded in 34 out of 48 files only. Pre- and 177 
intraoperatively, the glycemia was assessed on whole blood with a glucometer specifically 178 
designed for veterinary patientss. The time interval between subsequent intraoperative BG 179 
concentrations measurements was 30 min. At least one missing intraoperative BG value was 180 
found in 25% (n = 12) of the files. Therefore, a total of 19 out of 240 BG concentrations were 181 
replacement values obtained with data imputing.  182 
Intra-operative BG concentrations changed significantly compared to baseline values only 183 
in group D (P=.014; Figure 1). Overall, the four treatment groups (with insulin/fasting 184 
regime as treatment factor) were compared with respect to intraoperative BG concentrations, 185 
a statistically significant difference was found only between group B (14 [10–22] mg/dL) and 186 
group D (30 [17–34] mg/dL; P = .005). 187 
Regarding the choice of the anesthetic protocol, 42% of the dogs (n = 20) were included in 188 
group AO, whereas group O was composed of the remaining 58% (n = 28). The BG 189 
concentrations over time were not affected by the choice of the anesthetic protocol (P = .36). 190 
In group D, the frequency of intraoperative administration of insulin, carried out on a case-191 
by-case basis at the anesthetist's discretion, was higher than in any other group, and this 192 
difference was statistically significant (P < .001; Table 1). None of the patients experienced 193 
intraoperative hypoglycemia. There were no statistically significant associations between the 194 
treatment group (A, B, C, or D; AO or O) and the occurrence of intraoperative complications 195 
or the presence of underlying diagnosed comorbidities. The comorbidities represented in the 196 
study population were mitral valve disease (n = 7), chronic bronchitis (n = 1), pancreatitis (n 197 
= 6), gall bladder mucocele (n = 1), and hyperadrenocorticism (n = 5). Of the 16 patients with 198 
diagnosed comorbidities, 25% (n = 4) had more than one condition at the same time. The 199 
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proportions and numbers of dogs experiencing intra-operative complications within each 200 
treatment group are shown in Table 1. 201 
 202 
Discussion 203 
The findings of this study indicate that the use of insulin before surgery results in lesser 204 
increase of BG intraoperatively, as compared with preanesthetic values, than insulin 205 
withdrawal. 206 
Anesthesia may alter the delicate endocrine balance of diabetic patients by triggering a 207 
stress response through a complex interplay involving the hypothalamic–pituitary axis, the 208 
neuroendocrinal system, and the autonomic nervous system.14 The net result of such neuro-209 
endocrinal outflow is a hypermetabolic state characterized by hyperglycemia.14 210 
Unsurprisingly increases in cortisol and BG concentrations are commonly observed during 211 
anesthesia in non-diabetic animals and humans.14-16 Presumably, patients with diabetes 212 
mellitus, especially if the condition is poorly controlled medically, may experience a less 213 
predictable, and possibly more pronounced, neuro-endocrine response to anesthesia, resulting 214 
in uncontrolled hyperglycemia. If this were true, it would be reasonable to expect the 215 
hyperglycemia to be at least partially refractory to the usual insulin dose, and more 216 
challenging to stabilize in case of pre-operative insulin withdrawal.  217 
The preoperative administration of half insulin dose is a common choice at the referral 218 
center where the study was carried out. In dogs fasted for 6 hr, the rationale behind this 219 
protocol is the need to control the perioperative glycemia in diabetic patients whose surgery 220 
is scheduled in the early afternoon. These patients are fed a light meal (usually half of their 221 
canned food dose) ∼6 hr before surgery, and the clinicians halve the insulin dose in an 222 
attempt to avoid sudden hypoglycemia because the food intake is smaller than usual. At our 223 
referral center, some anesthetists also halve the insulin after 12 hr of fasting in order to 224 
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reduce the chances of a dog developing a hypoglycemic episode after having received insulin 225 
and no food. 226 
Altogether, these findings suggest that administering insulin in the pre-anesthetic 227 
period may be a better clinical choice than not administering it. This information may be of 228 
help when making general recommendations and supporting the development of future 229 
studies. However, it is worth to mention that stability of the BG concentrations throughout 230 
the peri-operative period does not necessarily imply an adequate medical control of diabetes, 231 
a condition whose clinical evaluation is complex and should be based on more than one 232 
parameter. Moreover, clinicians need to be aware that pre-operative fasting requires frequent 233 
checking of a patient’s BG concentrations to prevent a hypoglycemic episode.   234 
Although the baseline BG concentrations obtained prior to anesthesia were not 235 
statistically different between groups, it is worth considering that nonhyperglycemic dogs 236 
were more represented in group D than in the other groups. This could have affected the 237 
decision of the anesthetists in charge not to administer preoperative insulin, as reasonably the 238 
clinicians would have been more likely to withhold insulin in hypoglycemic and 239 
normoglycemic patients rather than in dogs with hyperglycemia. 240 
As it is generally advised that patients should be in as optimal a general health 241 
condition as possible for general anesthesia, one could assume that most patients referred for 242 
an elective procedure have achieved adequate stabilization of any underlying medical 243 
condition prior to the referral for anesthesia and surgery. Unfortunately, this is not always the 244 
case. Although fructosamine serum measurements were available only in a few patients, it 245 
should be noted that half of the values were above 500 µmol/L, which has been defined as the 246 
cut off value for a poorly controlled condition.17 It is possible that patients without 247 
fructosamine readings had sub-optimal glycemic control. If this were true, it would be 248 
reasonable to assume that poorly controlled diabetes, a condition that might exacerbate the 249 
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effect of anesthesia on the glycemic control, could have been common in the study 250 
population. It should be recommended as standard practice that diabetic patients for whom 251 
general anesthesia is scheduled undergo not only routine preanesthetic baseline BG 252 
measurement but also a thorough medical evaluation of the diabetes, which might include 253 
fructosamine assay or glycemic curves, before being anesthetized. 254 
As a result of its retrospective nature, this study has several limitations. Some of the 255 
patients who had been included in the study after a preliminary search had incomplete files 256 
for which they had to be excluded, or had their last preanesthetic BG concentration measured 257 
days or even weeks before the day of surgery, a drawback that, owing to the day-to-day 258 
variability of BG in diabetic dogs, could have jeopardized the accuracy of our findings.18 259 
This reduced considerably the number of patients to be included in the study, which may 260 
potentially represent a further source of bias. Another limitation pertains to the intraoperative 261 
BG concentrations, which were measured at ∼30 min intervals in most patients but not all as 262 
a result of financial constraints, or at the anesthetist’s discretion in cases with good glycemic 263 
control, where more frequent measurements were not deemed to be necessary. The data could 264 
be analyzed despite the missing values by applying item imputation, a statistical procedure 265 
widely used for this purpose.12 Further limitations worth consideration are the possible effect 266 
of the topical steroid, administered in the preoperative period and possibly absorbed 267 
systemically, on the glucose homeostasis,19 and the different sizes of the treatment groups, 268 
which is suboptimal. Finally, using patients undergoing cataract surgery helped focus the 269 
case capture effort and created a standardization of the cohort, but it risks adding a selection 270 
bias. 271 
Future studies should be prospective and standardize the time at which the baseline BG 272 
measurements are taken, randomize treatment groups that ideally would be of equal sizes and 273 
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including as many diabetic patients as possible to avoid a potential selection bias based on the 274 
presence of ophthalmic problems. 275 
 276 
Conclusion 277 
Several different insulin and fasting protocols may be used to anesthetize diabetic patients, 278 
with no clear benefit or risks from one protocol versus another. Compared with 279 
administration of either full or half insulin dose after 12 hr of fasting, or of half the insulin 280 
dose after 6 hr of fasting, administering no insulin on the morning of anesthesia in diabetic 281 
dogs resulted in greater increases of intraoperative BG, compared with preanesthetic values. 282 
Clinicians in charge of anesthetizing normoglycemic dogs were likely prompted to withhold 283 
the insulin on the morning of surgery; however, there is no evidence that this decision 284 
resulted in long-term differences in patient outcomes. These findings provide a basis for 285 
future prospective studies in diabetic dogs of insulin/fasting protocols prior to anesthesia.  286 
  287 
 
13 
 
FOOTNOTES 288 
a Acecare; Animalcare, UK 289 
b Methadone Hydrochloride; Martindale Pharmaceuticals, UK, or Synthadon; Animalcare, 290 
UK 291 
c Pethidine injection; Martindale Pharmaceuticals, UK 292 
d Alvegesic; Dechra, Italy 293 
e Propofol-® Lipuro; Virbac, Italy 294 
f Alfaxan; Jurox, UK 295 
g Sevoflo; Abbott, USA 296 
h Isoflo; Abbott, USA  297 
i SPSS Statistics 23; IBM Inc., Chicago, IL, USA 298 
j NCSS 9 and Pass 12 Statistical Software, NCSS LLC, NV, USA 299 
k SigmaStat 4.0 and SigmaPlot 14; Systat Software Inc, CA, USA 300 
l Caninsulin; Intervet, UK 301 
m Maxidex (R); Novartis Pharmaceuticals, Camberley, UK  302 
n Minims (R), Bausch and Lomb, Kingston upon Thames, UK 303 
o Ocufen (R); Allergen, Marlow, UK 304 
p Tracrium; GlaxoSmithKline, UK 305 
q Neostigmine Methylsulfate injection; Hameln Pharmaceutical, UK 306 
r Glycopyrronium Bromide; Martindale Pharmaceutical, UK 307 
s Alphatrak2; Abbott Laboratories, Abbott Park, IL, USA 308 
309 
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Figure legends 365 
FIGURE 1 Effects of four different insulin/fasting regimens (groups A, B, C, and D) on the 366 
intraoperative blood glucose concentrations over time (1: baseline; 2: 30 min; 3: 60 min; 4: 367 
90 min; 5: 120 min after anesthetic induction). The upper and lower quartiles (interquartile 368 
range box) represent the data greater (25%) and lesser (25%) than the median, respectively, 369 
accounting for 50% of the total data. The whiskers represent the ranges for the bottom 25% 370 
and the top 25% of the data values. The dots represent the outliers. The stars indicate 371 
statistically significant differences (P = .001) compared with baseline values. 372 
 373 
  374 
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TABLE 1  375 
Proportions and numbers of dogs, within each treatment group, experiencing intra-operative 376 
complications (hypotension, bradycardia and hyperglycemia), requiring intra-operative (IO) 377 
insulin administration and with a clinical history of co-morbidities.    378 
 379 
 
Group 
 
 
Hypotension 
 
Bradycardia 
 
Hyperglycemia 
 
Hypothermia 
 
Co-morbidities 
 
IO insulin 
 
A 
 
45% (n=9) 
P= .43 
 
 
10% (n=2) 
P= .17 
 
80% (n=16) 
P= .36 
 
50% (n=10) 
P= .63 
 
50% (n=10) 
P= .32 
 
20% (n=4) 
P= .13 
B 50% (n=6) 
P= .43 
 
8% (n=1) 
P= .17 
83% (n=10) 
P= .36 
33% (n=4) 
P= .63 
42% (n=5) 
P= .32 
25% (n=3) 
P= .13 
C 72% (n=16) 
P= .43 
 
0% (n=0) 
P= .17 
82% (n=22) 
P= .36  
41% (n=9) 
P= .63 
23% (n=5) 
P= .32 
18% (n=4) 
P= .13 
D 50% (n=6) 
P= .43 
 
17% (n=2) 
P= .17 
50% (n=6) 
P= .36 
33% (n=4) 
P= .63 
17% (n=3) 
P= .32 
42% (n=5) 
P= .13 
AO 52% (n=15) 
P= .62 
 
7% (n=2) 
P= .33 
90% (n=26) 
P= .23 
55% (n=16) 
P= .62 
21% (n=6) 
P= .04
*
  
24% (n=7) 
P= 1 
O 55% (n=20) 
P= .62 
8% (n=3) 
P= .33 
62% (n=23) 
P= .23 
40% (n=15) 
P= .62 
46% (n=17) 
P= .04
*
   
24% (n=9) 
P=1 
 
 380 
 
* statistically significant  381 
